Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute-Phase Response”

145 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 145 results

Not applicableWithdrawnNCT00517231
What this trial is testing

Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis Treatment

Who this might be right for
Pulmonary Tuberculosis
UPECLIN HC FM Botucatu Unesp
Not applicableStudy completedNCT00952640
What this trial is testing

Making Maternal Post-partum Vitamin A Supplementation Effective: The Role of Timing and Inflammation

Who this might be right for
Healthy Women Giving Birth to Singleton Infants
Institut de Recherche pour le Developpement 400
Post-approval studies (Phase 4)UnknownNCT04719481
What this trial is testing

Pravastatin Reduces Acute Phase Response of Zoledronic Acid

Who this might be right for
Postmenopausal Osteoporosis
Peking University Third Hospital 110
Early research (Phase 1)Ended earlyNCT00672152
What this trial is testing

A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation

Who this might be right for
Acute Myelogenous Leukemia (AML)Chronic Myelogenous Leukemia (CML)Acute Lymphoblastic Leukemia (ALL)+2 more
Michael Morse, MD 8
Large-scale testing (Phase 3)Study completedNCT01757535
What this trial is testing

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

Who this might be right for
Leukemia, Myeloid, Acute
Celgene 472
Large-scale testing (Phase 3)Study completedNCT04611802
What this trial is testing

Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 33,000
Not applicableStudy completedNCT05413720
What this trial is testing

Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO

Who this might be right for
Leptospirosis
Centre Hospitalier Universitaire de la Réunion 100
Testing effectiveness (Phase 2)Study completedNCT00183261
What this trial is testing

Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Study completedNCT01474863
What this trial is testing

Citrulline in Severe Sepsis

Who this might be right for
Severe SepsisAcute Lung Injury
Vanderbilt University 72
Testing effectiveness (Phase 2)Study completedNCT02550535
What this trial is testing

A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients

Who this might be right for
Myelodysplastic Syndromes (MDS)Acute Myeloid Leukaemia (AML)
Cell Medica Ltd 3
Early research (Phase 1)Study completedNCT05138822
What this trial is testing

Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections

Who this might be right for
Uncomplicated Urinary Tract InfectionsUrinary Tract Infections
GlaxoSmithKline 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06308926
What this trial is testing

MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients

Who this might be right for
Acute Respiratory Distress SyndromeRespiratory FailureRespiratory Distress Syndrome+2 more
MedRegen LLC 60
Testing effectiveness (Phase 2)UnknownNCT01520558
What this trial is testing

CNDO-109-AANK for AML in First Complete Remission (CR1)

Who this might be right for
Acute Myeloid Leukemia
Coronado Biosciences, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT05996835
What this trial is testing

Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)

Who this might be right for
Acute Kidney Injury Due to Sepsis
Novartis Pharmaceuticals 320
Early research (Phase 1)UnknownNCT02515396
What this trial is testing

Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide

Who this might be right for
Acute Inflammatory Response to Non-antigenic Stimulus
Moerae Matrix, Inc. 20
Not applicableUnknownNCT05656339
What this trial is testing

Metabolic Effects of Whey Protein Supplementation After Fasting in Volunteers

Who this might be right for
KetosisAcute-Phase ResponseInsulin Resistance
Federal University of Mato Grosso 30
Testing effectiveness (Phase 2)Study completedNCT01283581
What this trial is testing

Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial Infections
Melinta Therapeutics, Inc. 256
Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8
Not applicableStudy completedNCT04838938
What this trial is testing

Personalized Medicine in Patients With Infective Endocarditis

Who this might be right for
Infective EndocarditisResponse, Acute PhaseTreatment
Fundación para la Investigación Biosanitaria del Principado de Asturias 32
Post-approval studies (Phase 4)Ended earlyNCT01128114
What this trial is testing

Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy

Who this might be right for
Acute Bipolar Mania
AstraZeneca 32
Load More Results